UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
UBS Maintains a 'Buy' on Cardiome (CRME), BRINAVESS Approval Imminent; Raising PT
-
Notable Analyst Rating Changes 1/13: BIDU, WYN, HMA, IACI, MRK Upgraded; ZEUS, AFFX, GSK, PCU Downgraded
-
Notable Analyst Rating Changes 12/16: CNQ, SCHW, RCL, CCL, NLY, GLW, BFS, ADBE Upgraded; AYE, FE, EIX, STLD Downgraded
-
UBS Modestly Positive On US Large-Cap Pharma (MRK, PFE, BMY, LLY)
-
Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG, MRK, TSL Highs; SNV, WNR Low
-
Notable Analyst Rating Changes: ARO, CSX, PFWD, SIRI Upgraded; BRCD, BNI Downgraded
-
Leerink Swann Upgrades Merck & Co (MRK) to Outperform; Near-Term Risks Already Factored In
-
Goldman Sachs Adds Merck (MRK) To Its Conviction Buy List
-
Trading Radar for 7/21: Apple (AAPL), Merck (MRK), Coca-Cola (KO), Cat (CAT), Freeport-McMoRan (FCX), Yahoo! (YHOO), State Street (STT), BlackRock (BLK), Amylin (AMLN), Starbucks (SBUX) Report
-
Merck & Co. (MRK) Slammed On Speculation After Trial Abruptly Halted
-
Morning Movers 6/11: STAA, CPST, HGSI, CHDX, MBRX, OBCI Higher; LULU, UNH, LUB, LTON, PNFP Lower
-
Morning Movers 4/21: ELX, THC, COH, PKG, HWG, USG Higher; ZION, LAB, NTRS, HBAN, BK, NYT Lower
-
David Moenning's Daily State of the Markets: 4/21
-
Trading Radar for 4/21: Yahoo! (YHOO), Coke (KO), US Bancorp (USB), Cat (CAT), Bank of NY Mellon (BK), DuPont (DD), Lockheed Martin (LMT), Schering-Plough (SGP), AMD (AMD), State Street (STT) Report
-
Morning Movers 4/9: TXT, WFC, APWR, CRME, USB, EXM, BAC, GYMB, CSH Higher; MOV, ELMG, ANF Lower
-
Cardiome Pharma (CRME) Signs Major License Agreement With Merck (MRK) for Vernakalant
-
Merck (MRK) Provides Update on Merger Financing
-
Notable Analyst Rating Changes 3/20: MRK, JAS, JNJ Upgraded; JCG, URBN, AN Downgraded
-
Morning Movers: Xerox (XRX) Lower On Profit Warning, Dry Bulk Shippers Lower On Downgrade (ESEA, EGLE, DSX)
-
David Moenning's Daily State of the Markets: 3/13
-
Morning Movers 3/9: Schering-Plough (SGP) Higher On Merck (MRK) Merger, Stem Cell Stocks Rock On Obama Move To Lift Funding Restrictions
-
Merck (MRK) To Acquire Schering-Plough (SGP) In $41 Billion Deal
-
David Moenning's Daily State of the Markets: 2/3
-
David Moenning's Daily State of the Markets: 1/23
-
Notable Analyst Rating Changes 11/07: ANF, TWTC, CECEO Upgraded; TM, DLB, SI Downgraded
-
David Moenning's Daily State of the Markets: 10/22
-
Notable Analyst Rating Changes 10/17: UNH, KFT, M, MRK Upgraded; SPWRA, ARM, FCX, MNST Downgraded
-
David Moenning's Daily State of the Markets: 10/17
-
UBS Upgrades Merck & Co. (MRK) to Buy
-
Pre-Open Movers 9/18: Investment Banks Still Under Pressure (GS, MS); WaMu (WM) Up On Deal Reports
-
David Moenning's Daily State of the Markets: 9/10
-
Notable Analyst Rating Changes 9/10: AEO, NSC, EV, NUE Upgraded; MRK, DRIV, STI, MPEL Downgraded
-
Pre-Open Movers 7/22: Assured Guaranty (AGO) Sinks On Possible Moody's Downgrade, Foundry Networks (FDRY) Up on Buyout
-
Merck (MRK) Lower After UBS Cuts Their Rating to Neutral
-
David Moenning's Daily State of the Markets: 7/7
-
Notable Analyst Rating Changes 7/7: SU, JNPR, ENER Upgraded; MRK, TWX, DIS Downgraded
-
UBS Downgrades Merck (MRK) to Neutral
-
David Moenning's Daily State of the Markets: 3/31
-
David Moenning's Daily State of the Markets: 1/30
-
Notable Analyst Rating Changes 1/28: CAT, MRK, K, GIS, FCX Upgraded; WAG, FUL, MTL Downgraded
-
UBS Upgrades Merck (MRK) to Buy
